Becton Dickinson and Company (BDX)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $58.96B
Last updated: Nov 17, 2026 at 4:24 PM ET
Becton Dickinson and Company (BDX) Statistics
Becton Dickinson and Company (BDX) has a market cap of $58.96B and an enterprise value of $75.06B. Its share count is down 4.97% from a year earlier. Its return on invested capital of 4.99% compares with a 10.24% median across 11 similar companies.
Total Valuation
Enterprise value is 27.30% above the market cap, as debt exceeds cash.
| Market Cap | $58.96B |
|---|---|
| Enterprise Value | $75.06B |
| Latest price (Nov 17, 2026) | $215.44 |
Key Dates
The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 10, 2026.
| Next Earnings Date | Feb 8, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Next Ex-Dividend Date | Dec 10, 2026 |
| Next Payment Date | Dec 31, 2026 |
| Fiscal Year End | September |
Valuation Ratios
Sales and book value multiples are 2.6x and 2.4x. Its year-end P/E ranged from 14.0x to 23.4x from 2016 to 2025.
| P/E Ratio | 16.3x |
|---|---|
| Forward P/E | 16.0x |
| P/S Ratio | 2.6x |
| Forward P/S | 3.0x |
| P/B Ratio | 2.4x |
| P/FCF Ratio | 18.3x |
| P/OCF Ratio | 14.9x |
| PEG Ratio | 2.5 |
Enterprise Valuation
Counting debt and cash, the company is valued at 15.5x EBITDA and 23.3x free cash flow.
| EV / Earnings | 79.8x |
|---|---|
| EV / Sales | 3.3x |
| EV / EBITDA | 15.5x |
| EV / EBIT | 31.8x |
| EV / FCF | 23.3x |
Price Statistics
The stock is up 44.65% over 52 weeks and trades 12.04% above its 50-day average.
| Beta (1Y) | 0.26 |
|---|---|
| 52-Week Change | +44.65% |
| 1-Month Change | +12.95% |
| 3-Month Change | +15.51% |
| 6-Month Change | +48.48% |
| 5-Year Change | -17.41% |
| 10-Year Change | +17.85% |
| Total Return (1Y) | +47.32% |
| Total Return (3Y CAGR) | +7.48% |
| Total Return (5Y CAGR) | +4.14% |
| Return vs SPY (1Y) | +33.63% |
| Max Drawdown (1Y) | -23.53% |
| Max Drawdown (3Y) | -33.39% |
| Sharpe Ratio (1Y) | 1.43 |
| Correlation with SPY (1Y) | 0.14 |
| 50-Day Average | $192.29 |
| 200-Day Average | $168.00 |
| 52-Week Range | $139.29 to $220.36 |
| RSI (14 Days) | 69.8 |
| Average Volume (20 Days) | 2.03M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.87x current liabilities, and total debt is 0.69x shareholder equity.
| Current Ratio | 0.87x |
|---|---|
| Quick Ratio | 0.51x |
| Debt / Equity | 0.69x |
| Debt / EBITDA | 3.49x |
| Debt / FCF | 5.25x |
| Interest Coverage | 4.00x |
Returns and Efficiency
Return on invested capital is 4.99% over the last 12 months, against a 5-year average of 4.72%.
| Return on Equity (ROE) | 3.85% |
|---|---|
| Return on Assets (ROA) | 1.85% |
| Return on Invested Capital (ROIC) | 4.99% |
| Return on Capital Employed (ROCE) | 5.71% |
| ROE (5Y Average) | 6.96% |
| ROA (5Y Average) | 3.21% |
| ROIC (5Y Average) | 4.72% |
| Asset Turnover | 0.42x |
| Inventory Turnover | 3.58x |
| Receivables Turnover | 9.81x |
| Cash Conversion Cycle | -45 days |
Taxes
Income tax took 12.73% of pretax income over the last 12 months.
| Income Tax (TTM) | $228.00M |
|---|---|
| Effective Tax Rate | 12.73% |
Scores
BDX has an Altman Z-Score of 2.39, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.39 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $22.41B over the last 12 months is up 13.14% from the 12 months before.
| Revenue | $22.41B |
|---|---|
| Revenue Growth (YoY) | +13.14% |
| Gross Profit | $10.47B |
| Operating Income | $2.31B |
| Pretax Income | $1.79B |
| Net Income | $941.00M |
| EBITDA | $4.81B |
| EBIT | $2.36B |
| Reported EPS (TTM) | $13.19 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 48.14% of the $50.73B in total assets.
| Cash and Equivalents | $708.00M |
|---|---|
| Total Debt | $16.81B |
| Net Debt | $16.10B |
| Net Debt Per Share | $59.11 |
| Working Capital | -$1.26B |
| Shareholder Equity | $24.42B |
| Book Value Per Share | $89.64 |
| Tangible Book Value | -$3.89B |
| Total Assets | $50.73B |
| Total Liabilities | $26.31B |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $753.00M of capital spending, operating cash flow left $3.20B of free cash flow.
| Operating Cash Flow | $3.96B |
|---|---|
| Capital Expenditures | $753.00M |
| Free Cash Flow | $3.20B |
| FCF Per Share | $11.76 |
| Depreciation and Amortization | $2.45B |
| Dividends Paid | $1.17B |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is 10.31%, against a 5-year average of 11.69%.
| Gross Margin | 46.73% |
|---|---|
| Operating Margin | 10.31% |
| Pretax Margin | 7.99% |
| Net Margin | 4.20% |
| EBITDA Margin | 21.46% |
| EBIT Margin | 10.52% |
| FCF Margin | 14.29% |
| Gross Margin (5Y Average) | 44.58% |
| Operating Margin (5Y Average) | 11.69% |
| Net Margin (5Y Average) | 8.83% |
Growth
Revenue grew 4.99% a year over 3 years, and EPS 2.58% a year.
| Revenue Growth (3Y CAGR) | +4.99% |
|---|---|
| Revenue Growth (5Y CAGR) | +6.32% |
| EPS Growth (3Y CAGR) | +2.58% |
| EPS Growth (5Y CAGR) | +0.18% |
| FCF Growth (3Y CAGR) | +21.25% |
| FCF Growth (5Y CAGR) | +4.25% |
| Operating Income Growth (3Y CAGR) | +4.16% |
| Book Value Per Share Growth (2Y CAGR) | +0.17% |
Dividends and Yields
BDX pays out 27.37% of earnings as dividends.
| Dividend Per Share (Annual) | $4.20 |
|---|---|
| Dividend Yield | 1.95% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +5.81% |
| Dividend Growth (5Y CAGR) | +5.44% |
| Payout Ratio | 27.37% |
| FCF Payout Ratio | 36.59% |
| Earnings Yield | 6.13% |
| FCF Yield | 5.46% |
| Buyback Yield | 4.26% |
| Shareholder Yield | 6.26% |
Peer Position
Against 12 similar companies, BDX has the 9th highest P/E and the 9th highest P/S.
P/E RatioPeer median 20.7x
P/S RatioPeer median 3.4x
ROICPeer median 10.24%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.05%
Dividend YieldPeer median 0.00%
| P/E Ratio | 16.3x vs 20.7x median |
|---|---|
| P/S Ratio | 2.6x vs 3.4x median |
| ROIC | 4.99% vs 10.24% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +13.14% vs +9.05% median |
| Dividend Yield | 1.95% vs 0.00% median |
Analyst Forecast
Consensus estimates put EPS growth at 3.85% a year over the next 2 fiscal years.
| EPS Growth Forecast (2Y CAGR) | +3.85% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BDX
What is BDX's market cap?
Becton Dickinson and Company has a market cap of $58.96B. Its enterprise value, which adds debt and subtracts cash, is $75.06B.
What is BDX's P/E ratio?
Becton Dickinson and Company has a trailing P/E ratio of 16.3x and a forward P/E of 16.0x.
How many shares of BDX are outstanding?
Becton Dickinson and Company has 272.39M shares outstanding. The count is down 4.97% from a year earlier.
Does BDX pay a dividend?
Yes. Becton Dickinson and Company pays $4.20 a share a year, a dividend yield of 1.95%.
How much debt does BDX have?
Becton Dickinson and Company has $16.81B of total debt and $708.00M of cash and equivalents, a net debt position of $16.10B.
BDX pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors